Clinical Trials Logo

Filter by:
NCT ID: NCT02458027 Completed - Obesity Prevention Clinical Trials

Acute Food INtake Effect of Hemp Protein (A FINEH Protein) Trial - Part 2

Start date: July 2015
Phase: N/A
Study type: Interventional

The objectives of this trial are to investigate whether the effects of hemp protein on glycemic and appetite control are insulin-dependent by measuring 1) blood glucose, insulin and appetite for one hour following consumption, 2) blood glucose, insulin and appetite following a fixed energy meal to determine the "second meal effect" of hemp protein versus soybean protein and a non-protein control.

NCT ID: NCT02457858 Completed - Type 1 Diabetes Clinical Trials

Islet Isolation Using MnTE-2-PyP (BMX-010) - Pilot Study

Start date: August 2014
Phase: Phase 1
Study type: Interventional

In this study, the investigators hypothesize that the addition of antioxidant BMX-010 to perfusion solution, digestion solution and culture medium during islet isolation process, can lead to greater preservation of islet mass and metabolic function, such as improved islet yield, viability, and functional potency. This pilot study will involve up to 10 participants from the islet transplant waiting list at the Clinical Islet Transplant Program. All participants will receive islets isolated with the medication BMX-010. This is to assess the primary safety of BMX-010 on pancreata and islets. BMX-010 will be used only in the islet isolation process, and will not be given to participants as medication.

NCT ID: NCT02457741 Completed - Clinical trials for Acute Respiratory Distress Syndrome

Validation of a Simple Approach to Estimate Alveolar Recruitability in ARDS Patients

Start date: June 2015
Phase:
Study type: Observational

This study will test the validity of a new approach to assess alveolar recruitability at the bedside in comparison to direct measurements of lung volume and derecruitment.

NCT ID: NCT02457546 Completed - Clinical trials for Cerebrospinal Fluid Leak

The EVICEL® Neurosurgery Phase III Study

Start date: July 1, 2015
Phase: Phase 3
Study type: Interventional

The objective of this study is to evaluate the safety and efficacy of EVICEL® Fibrin Sealant (Human) for use as an adjunct to sutured dural repair in cranial surgery.

NCT ID: NCT02457351 Completed - Medical Oncology Clinical Trials

Roniciclib (BAY 1000394) Drug-Drug Interaction (DDI) Study

Start date: July 2015
Phase: Phase 1
Study type: Interventional

To evaluate the effect of itraconazole, a strong CYP3A4 inhibitor, on the pharmacokinetics of roniciclib in cancer patients. To assess safety and tolerability of roniciclib dosing when administered with and without itraconazole in cancer patients

NCT ID: NCT02457143 Completed - Cancer Clinical Trials

Comparing Methods of Recall for Cancer Screening in Primary Care: a Pragmatic Clinical Trial

Start date: July 2015
Phase: N/A
Study type: Interventional

This randomized trial aims to understand how effective a reminder letter is compared to a reminder phone call in improving breast, cervical and colorectal cancer screening rates and reducing screening disparities.

NCT ID: NCT02456805 Completed - Clinical trials for Gastrointestinal Tolerance

Alternate Formula Feedings in Formula Intolerant Infants

Start date: August 1996
Phase: N/A
Study type: Interventional

This study assessed tolerance improvement of a formula change in healthy term infants with perceived intolerance to their current milk-based formula feeding.

NCT ID: NCT02456740 Completed - Migraine Clinical Trials

Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) in Migraine Prevention

STRIVE
Start date: July 17, 2015
Phase: Phase 3
Study type: Interventional

The primary objective of the study was to evaluate the effect of erenumab compared to placebo on the change from baseline in monthly migraine days.

NCT ID: NCT02456428 Completed - Clinical trials for Type 2 Diabetes Mellitus

Incretin-based Drugs and the Risk of Heart Failure

Start date: March 2014
Phase: N/A
Study type: Observational

The purpose of this study is to determine whether incretin-based drugs (used to treat type 2 diabetes) taken either alone or in combination with other anti-diabetic drugs are associated with an increased risk of heart failure (HF) compared to other combinations of oral hypoglycemic agents (OHA). The investigators will carry out separate population based cohort studies using administrative health databases in six jurisdictions in Canada, the US and the UK. Cohorts will be defined by the initiation of a new anti-diabetic drug when incretin-based drugs entered the market, with follow-up until hospitalization for HF. Analyses will be done separately for groups of patients with and without prior HF. The results from the separate sites will be combined to provide an overall assessment of the risk of HF in users of incretin-based drugs and by class of incretin-based drugs.

NCT ID: NCT02456311 Completed - Lung Cancer Clinical Trials

Pulmonary Artery Harmonic Ace+7 Energy Sealing in Open Lobectomy

Start date: May 2015
Phase: Phase 0
Study type: Interventional

VATS anatomical lung resection provides an effective minimally invasive treatment strategy for stage I and II lung cancer. VATS lobectomy is associated with significantly less postoperative atrial fibrillation, blood transfusion, renal failure, and other complications when compared with lobectomy via thoracotomy. Although VATS lobectomy has been proven to be effective and safe in experienced hands, it is not devoid of risk. Intra-operative surgical complications can be at times catastrophic. Complications include: pulmonary vascular injuries (PA, pulmonary vein) necessitating urgent conversion to open thoracotomy and even death14. Causes of conversion included PA injury, difficult anatomy, bulky/calcified lymph nodes, and technical problems including stapler misfire. PA injury alone constituted 37.5% of all conversions. Proper dissection of all tissue around PA branches is sometime difficult especially in the presence of adhesions or large, calcified lymph nodes and may increase the risk of vascular injury. Currently, in spite of being a safe and effective technique in experienced hands, a minority of anatomical pulmonary resections are being performed by VATS. In an analysis utilizing the Nationwide Inpatient Sample (NIS) database in the United States, only 15% of anatomical lung resections were performed by VATS. The technical difficulty and danger of VATS lobectomy is directly related to PA branch manipulation, stapling and division. PA manipulation is the main hesitation of many thoracic surgeons regarding the adoption of VATS lobectomy. The investigators believe that by decreasing the manipulation and dissection required by the surgeon on the PA branches, these procedures will be safe and therefore more prevalent for anatomical pulmonary resections.